Bedaquiline alone will not completely cure tuberculosis and needs to be combined with other anti-tuberculosis mycobacteria medications (e.g., isoniazid, rifampicin, etc.) in order to have a chance of completely curing tuberculosis. Bedaquiline is a diarylquinoline anti-mycobacterium tuberculosis drug that is part of a combination therapy and cannot be used alone for the treatment of multidrug-resistant tuberculosis in adults. Patients with tuberculosis should only be considered to use to bedaquiline in combination with other anti-mycobacterial drugs such as isoniazid, pyrazinamide, ethambutol, etc., which have the potential to cure tuberculosis completely, if other effective treatment options are not available. ADVERSE REACTIONS: Bedaquiline may cause serious adverse reactions such as hepatotoxicity, increased mortality, and prolonged QT interval. Common adverse drug reactions caused by it, mainly include nausea, arthralgia, headache, chest pain, loss of appetite, and rash. Contraindication: Bedaquiline needs to be contraindicated for those who are allergic to it. Precautions: Bedaquiline needs to be swallowed whole and taken with food. The drug should be used in combination with other drugs to ensure compliance throughout the course of treatment. Patients with tuberculosis must use bedaquiline only if they meet the indications and must take it under the supervision of a doctor, individuals should not abuse the drug.